SUBSCRIBE
SUBSCRIBE
News   Business

Myriad Genetics, Inc. Reports Results for Third Quarter of Fiscal 2007

May 1, 2007 | 
1 min read
SALT LAKE CITY, UT -- (MARKET WIRE) -- May 01, 2007 -- Myriad Genetics, Inc. (NASDAQ: MYGN) (www.myriad.com) today reported consolidated financial results for the third quarter of fiscal 2007 and the nine months ended March 31, 2007.
Earnings
MORE ON THIS TOPIC
Sign of divorce. Broken paper heart on blue background, top view, copy space
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Tablets. Medicinal capsules on a white background. pharmacies in the country. medicines in the state. Lots of capsules for treatment. Pharmacy network of the country.
Opinion
The Urgent Need To Redefine the Future of UK Biotech
October 1, 2025
 · 
6 min read
 · 
Kerstin Papenfuss
Company downsizing, staff reduction and layoffs. Employee dismissal, firing and unemployment. Business concept.
Layoffs
Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout
September 30, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac